These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 18005201)

  • 1. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.
    Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA
    BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K; Poulsen AL
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder.
    Westney OL; Pisters LL; Pettaway CA; Tu SM; Pollack A; Dinney CP
    J Urol; 1998 Mar; 159(3):792-5. PubMed ID: 9474150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD; Turner WH; Fleischmann A; Markwalder R; Thalmann GN; Studer UE
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection.
    Dhar NB; Klein EA; Reuther AM; Thalmann GN; Madersbacher S; Studer UE
    J Urol; 2008 Mar; 179(3):873-8; discussion 878. PubMed ID: 18221953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer.
    Shirotake S; Kikuchi E; Matsumoto K; Yazawa S; Kosaka T; Miyajima A; Nakagawa K; Oya M
    Jpn J Clin Oncol; 2010 Mar; 40(3):247-51. PubMed ID: 19887521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density.
    Wiesner C; Salzer A; Thomas C; Gellermann-Schultes C; Gillitzer R; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(3):331-5. PubMed ID: 19220265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy.
    Lambert EH; Pierorazio PM; Olsson CA; Benson MC; McKiernan JM; Poon S
    BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
    Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC
    Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.